Fertin Pharma

Executive Summary

Fertin Pharma is a Denmark-based Contract Development and Manufacturing Organization (CDMO) with over 30 years of expertise in oral and intra-oral drug delivery systems. Founded in 1992, the company uniquely blends pharmaceutical science with confectionery technology to develop and produce pleasant-tasting, effective nutraceutical and pharmaceutical products. Fertin supports partners throughout the entire product lifecycle, from concept development to full-scale commercial manufacturing. The CDMO's focus on oral delivery formats, such as medicated chewing gums, oral thin films, and lozenges, positions it well to capitalize on the growing demand for patient-friendly and non-invasive drug administration. As a private company with a specialized niche, Fertin Pharma is likely strengthening its capabilities and expanding its client base to address increasing interest from pharmaceutical companies seeking innovative oral delivery solutions that enhance compliance and patient acceptance.

Upcoming Catalysts (preview)

• Q4 2026Strategic partnership with a major pharma for oral thin film or chewable tablet product60% success
• Q2 2027Announcement of manufacturing capacity expansion or new facility50% success
• TBDLaunch of proprietary drug delivery platform leveraging confectionery expertise40% success